SCHEMBL7621095

SCHEMBL7621095

O=[C]c1ccncc1C(=O)c1ccncc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
LTA4H P09960 1/20 0.43
LMNA P02545 1/20 0.43
NAPRT Q6XQN6 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 3/20 0.38
TDP1 Q9NUW8 2/20 0.37
SIRT3 Q9NTG7 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
KDM4E B2RXH2 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 2/20 0.36
MPO P05164 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CYP2A6 P11509 1/20 0.36
ROCK2 O75116 1/20 0.36
ROCK1 Q13464 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7619693 0.85 ALDH1A1 (0.49) KMT2AMEN1LMNAALDH1A1TDP1
SCHEMBL10526335 0.79 KDM4C (0.50) KMT2AMEN1NAPRTL3MBTL1ALDH1A1
SCHEMBL5051470 0.78 SIRT3 (0.56) KMT2AMEN1L3MBTL1ALDH1A1TDP1
SCHEMBL4581478 0.76 KMT2A (0.52) KMT2AMEN1L3MBTL1ALDH1A1TDP1
SCHEMBL22492820 0.74 ROCK2 (0.57) KMT2AMEN1LTA4HLMNANAPRT
SCHEMBL29374289 0.73 SIRT3 (0.55) KMT2AMEN1LTA4HLMNANAPRT
SCHEMBL15645364 0.73 SIRT3 (0.42) KMT2AMEN1NAPRTL3MBTL1ALDH1A1
SCHEMBL8060987 0.71 ALDH1A1 (0.49) KMT2AMEN1LMNAALDH1A1TDP1
SCHEMBL725064 0.71 KMT2A (0.80) KMT2AMEN1LTA4HLMNANAPRT
SCHEMBL2745986 0.69 KMT2A (0.47) KMT2AMEN1LTA4HLMNANAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6353009-B1 TREATMENT OF GOUT WITH ANTIINFLAMMATORY AGENTS SANKYO COMPANY, LIMITED (JP) 2002-03-05 US disclosed
US-6103870-A INHIBITS BINDING BETWEEN VLA-4 RECEPTOR EXPRESSED ON INFLAMMATORY LEUKOCYTES AND FIBRONECTIN CS-1 PEPTIDE EXPRESSED ON ENDOTHELIAL CELLS; ANTIINFLAMMATORY AGENTS; ANTIARTHRITIC AGENTS; TREATMENT OF ASTHMA CYTEL CORPORATION (US) 2000-08-15 US disclosed